| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 15.539 | 13.981 | 16.651 | 23.170 | 22.738 | 22.688 | 24.570 | 23.473 | 22.866 | 25.446 |
| Total Income - EUR | 15.539 | 13.981 | 16.651 | 23.170 | 22.773 | 22.688 | 24.570 | 23.473 | 22.868 | 25.449 |
| Total Expenses - EUR | 13.375 | 13.814 | 14.493 | 14.865 | 15.616 | 10.361 | 11.814 | 10.840 | 6.681 | 10.214 |
| Gross Profit/Loss - EUR | 2.164 | 167 | 2.158 | 8.305 | 7.157 | 12.327 | 12.756 | 12.633 | 16.187 | 15.234 |
| Net Profit/Loss - EUR | 1.698 | -113 | 1.992 | 8.073 | 6.929 | 11.697 | 12.078 | 11.943 | 13.649 | 12.846 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Biopt Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 107.602 | 104.591 | 100.918 | 97.391 | 94.036 | 90.828 | 87.318 | 86.317 | 84.788 | 83.053 |
| Current Assets | 20.227 | 26.041 | 26.717 | 35.780 | 33.414 | 35.035 | 39.445 | 36.600 | 37.398 | 38.016 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 19.553 | 25.854 | 23.640 | 34.706 | 32.686 | 31.340 | 36.127 | 36.089 | 20.741 | 36.952 |
| Cash | 674 | 187 | 3.077 | 1.074 | 728 | 3.695 | 3.318 | 510 | 16.657 | 1.064 |
| Shareholders Funds | 122.556 | 120.680 | 117.444 | 123.361 | 118.068 | 120.729 | 122.043 | 118.893 | 120.275 | 118.876 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 5.273 | 9.952 | 10.191 | 9.810 | 9.383 | 5.134 | 4.720 | 4.024 | 1.911 | 2.194 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "2829 - 2829" | |||||||||
| CAEN Financial Year |
2829
|
|||||||||
Comments - Biopt Srl